These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 9000128

  • 21. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL, Yee CL, Münger K.
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [Abstract] [Full Text] [Related]

  • 22. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK, Jha HC, El-Naccache DW, Robertson ES.
    Oncotarget; 2016 Apr 05; 7(14):18116-34. PubMed ID: 26908453
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
    Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES.
    PLoS Pathog; 2011 Feb 10; 7(2):e1001275. PubMed ID: 21347341
    [Abstract] [Full Text] [Related]

  • 25. Induction of a complex between rasGAP and a novel 110 kD protein is required for immortalization of primary epithelial cells by the E1A 12S oncoprotein of adenovirus.
    Gopalakrishnan S, Fischer RS, Quinlan MP.
    Oncogene; 1996 Dec 19; 13(12):2659-69. PubMed ID: 9000140
    [Abstract] [Full Text] [Related]

  • 26. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
    Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, Szekely L.
    Exp Cell Res; 2005 Feb 01; 303(1):47-55. PubMed ID: 15572026
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
    Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES.
    Virology; 2009 Jun 05; 388(2):236-47. PubMed ID: 19394062
    [Abstract] [Full Text] [Related]

  • 28. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP.
    J Med Virol; 1999 Jan 05; 57(1):36-46. PubMed ID: 9890420
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
    Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L.
    Oncogene; 2000 Mar 30; 19(14):1801-6. PubMed ID: 10777214
    [Abstract] [Full Text] [Related]

  • 30. Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.
    Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ.
    J Virol; 2001 Aug 30; 75(16):7749-55. PubMed ID: 11462050
    [Abstract] [Full Text] [Related]

  • 31. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA.
    Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091
    [Abstract] [Full Text] [Related]

  • 32. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A, Schmidt D, Müller S.
    Oncogene; 2005 May 26; 24(23):3810-8. PubMed ID: 15806172
    [Abstract] [Full Text] [Related]

  • 33. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
    Krauer KG, Buck M, Belzer DK, Flanagan J, Chojnowski GM, Sculley TB.
    Virology; 2004 Jan 05; 318(1):280-94. PubMed ID: 14972554
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29997218
    [Abstract] [Full Text] [Related]

  • 35. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 15; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 36. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Berezutskaya E, Yu B, Morozov A, Raychaudhuri P, Bagchi S.
    Cell Growth Differ; 1997 Dec 15; 8(12):1277-86. PubMed ID: 9419416
    [Abstract] [Full Text] [Related]

  • 37. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S, Pei Y, Lang F, Sun K, Singh RK, Lamplugh ZL, Saha A, Robertson ES.
    PLoS Pathog; 2019 Jan 15; 15(1):e1007514. PubMed ID: 30615685
    [Abstract] [Full Text] [Related]

  • 38. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, Robertson ES.
    J Virol; 2013 Nov 15; 87(22):12121-38. PubMed ID: 23986604
    [Abstract] [Full Text] [Related]

  • 39. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC.
    PLoS Pathog; 2018 Aug 15; 14(8):e1007221. PubMed ID: 30125329
    [Abstract] [Full Text] [Related]

  • 40. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC, Shukla SK, Lu J, Aj MP, Banerjee S, Robertson ES.
    Oncotarget; 2015 Oct 06; 6(30):30115-29. PubMed ID: 26336822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.